LigaChem Biosciences

141080.KQ

70.79 USD

3.73

+5.56%

Overview

Last close

70.79 usd

Market cap

2.58B usd

52 week high

100.30 usd

52 week low

24.64 usd

Target price

106.45 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

48.0818

Price/Book Value

5.5615

Enterprise Value

2.07B usd

EV/Revenue

29.8485

EV/EBITDA

2642.0853

Key financials

Revenue TTM

52.23M usd

Gross Profit TTM

12.23M usd

EBITDA TTM

-33.25M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

739.33B usd

Net debt

N/A usd

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.